The goal of my research program is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies in the context of limited resources, and to provide better modeling tools for policy decisions. My team and I develop state-of-the-art transmission-dynamic models, analyze large population-level datasets, and use epidemiology and health economics to estimate the effectiveness and cost-effectiveness of infectious disease control and prevention strategies at the population-level and within vulnerable or at-risk groups.
‘Cost-effectiveness of extending human papillomavirus vaccination to population subgroups older than 26 years who are at higher risk for human papillomavirus infection in the United States’
Our team contributed two articles to the October-November 2024 issue of the JNCI Monograph, focusing on the State of the Science of Single-Dose Prophylactic HPV Vaccination
Marc Brisson, Mélanie Drolet, and Élodie Bénard participated in the International Papillomavirus Conference (IPVC) 2024 held from November 12-15 in Edimburgh, UK.
Marc Brisson presented ‘Optimal HPV vaccination strategies in low- and lower-middle income countries (LMICs)’ on November 8, at the Infectious Disease Modelling Conference 2024 (IDM2024) held November 6-8, 2024 in Bangkok, Thailand.
Marc Brisson and JF Laprise, in collaboration with Thailand’s Health Intervention and Technology Assessment Program (HITAP), conducted a workshop titled ‘Knowledge Translation Workshop: Mathematical Modeling to inform HPV Policy Decisions’ in Bangkok, Thailand, on November 4-5, 2024.